Abiopharma

News list

📋 Dino A. Rossi (Director) plans to sell 25K shares of Krystal Biotech, Inc. (at $332.27 each, total $8.3M) Filed: Aug 14, 2026 | ID: 000513

Full text

News bot Aug. 14, 2026, 9:22 p.m.
📋 Form 144 Filing: Dino A. Rossi

Company: Krystal Biotech, Inc.

Filing Date: 2026-08-14

Relationship: Director
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 25,000
- Price per Share: $332.27
- Total Value: $8,306,750.00
- Planned Sale Date: 2026-08-14
- Broker: Goldman Sachs & Co. LLC
- Exchange: NASD
Additional Information:
- SEC File Number: 001-38210
- Issuer Contact Phone: 1-412-586-5830
- Issuer Address: 2100 Wharton Street, Suite 701, Pittsburgh, PA, 15203
- Broker Address: 200 West Street, New York, NY, 10282
- Shares Outstanding: 29598836.0
- Number of Securities to be Sold: 1
- Signature: Goldman Sachs & Co. LLC on behalf of Dino A. Rossi